Breaking News Instant updates and real-time market news.

09:25
05/26/20
05/26
09:25
05/26/20
09:25

Cowen biotechnology analysts to hold an analyst/industry conference call

Biotech Analysts Nadeau, Peaker and Frahm, along with a Key Opinion Leader, provides a preview of the upcoming Virtual Annual Meeting of ASCO 2020 on an Analyst/Industry conference call to be held on May 26 at 10 am.

TODAY'S FREE FLY STORIES

Hot Stocks
Humana awarded Medicaid contract from Kentucky CHFS » 18:26
05/29/20
05/29
18:26
05/29/20
18:26
HUM

Humana

$411.26 /

+7.275 (+1.80%)

Humana has been selected…

Humana has been selected by the Kentucky Cabinet for Health and Family Services to continue serving children and adults across the health company's home state of Kentucky through the Department for Medicaid Services. Humana currently provides coordinated medical, wellness, and pharmacy benefits coverage and services to 150,000 Kentucky Medicaid recipients. The new contract supports the company continuing its longstanding community presence, strong provider partnerships, and unique commitment to population health. "The decision by the Commonwealth of Kentucky means a great deal to all of us at Humana. As a company with deep roots in the Commonwealth and a team of 12,000 employees in Kentucky, our commitment to serve our members and improve health across Kentucky is unyielding," said Jeb Duke, Humana's Kentucky-based Medicaid leader. "We were born in the Bluegrass nearly 60 years ago, and we've been fortunate through the years to be able to help our families, friends and neighbors live healthier lives. We commend the state for moving forward with enhancements to Medicaid that will better support people receiving coverage through the program." Under the terms of Kentucky CHFS's agreement, the renewed Medicaid program will begin enrolling eligible Kentuckians in January 2021. The statewide program will provide health care to approximately 1.26 million Medicaid enrollees. The statewide contract term is set to last through 2024, with the potential for an additional six two-year contract extensions.

ShowHide Related Items >><<
HUM Humana
$411.26 /

+7.275 (+1.80%)

HUM Humana
$411.26 /

+7.275 (+1.80%)

05/21/20 SunTrust
SunTrust raises price targets across select Healthcare Services names
05/04/20 Mizuho
Humana price target raised to $420 from $405 at Mizuho
04/30/20 Credit Suisse
Humana price target raised to $423 from $400 at Credit Suisse
04/30/20 Oppenheimer
Humana price target raised to $425 from $400 at Oppenheimer
HUM Humana
$411.26 /

+7.275 (+1.80%)

HUM Humana
$411.26 /

+7.275 (+1.80%)

HUM Humana
$411.26 /

+7.275 (+1.80%)

HUM Humana
$411.26 /

+7.275 (+1.80%)

Hot Stocks
Zscaler CEO: Companies built for the cloud will be winners » 18:24
05/29/20
05/29
18:24
05/29/20
18:24
ZS

Zscaler

$98.09 /

+22.21 (+29.27%)

In an interview on…

In an interview on CNBC's Mad Money, Jay Chaudhry said the biggest thing COVID-19 has done is accelerate digital transformation. He said Zscaler is well positioned to capitalize on the work from home trend that has resulted from the pandemic.

ShowHide Related Items >><<
ZS Zscaler
$98.09 /

+22.21 (+29.27%)

ZS Zscaler
$98.09 /

+22.21 (+29.27%)

05/29/20 Baird
Zscaler price target raised to $100 from $80 at Baird
05/29/20 Rosenblatt
Zscaler price target raised to $115 from $75 at Rosenblatt
05/29/20 DA Davidson
Zscaler price target raised to $105 from $65 at DA Davidson
05/29/20 Cowen
Zscaler price target raised to $100 from $80 at Cowen
ZS Zscaler
$98.09 /

+22.21 (+29.27%)

ZS Zscaler
$98.09 /

+22.21 (+29.27%)

ZS Zscaler
$98.09 /

+22.21 (+29.27%)

ZS Zscaler
$98.09 /

+22.21 (+29.27%)

Hot Stocks
Lufthansa board accepts commitments offered by Germany to EU » 18:11
05/29/20
05/29
18:11
05/29/20
18:11
DLAKY

Lufthansa

$0.00 /

+ (+0.00%)

The Lufthansa Executive…

The Lufthansa Executive Board has decided to accept the commitments offered by Germany to the EU Commission for the stabilization package negotiated with the Economic Stabilization Fund of the Federal Republic of Germany. The scope of the conditions required in the EU Commission's view has been reduced in comparison with initial indications. Lufthansa will therefore be obliged to transfer to one competitor each at the Frankfurt and Munich airports up to 24 take-off and landing rights, i.e. three take-off and three landing rights per aircraft and day, for the stationing of up to four aircraft. For one and a half years, this option is only available to new competitors at the Frankfurt and Munich airports. If no new competitor makes use of this option, it will be extended to existing competitors at the respective airports. The slots will be allocated in a bidding process. The slots can only be taken over by a European competitor that has not itself received any substantial state recapitalization as a result of the corona pandemic. The Supervisory Board must approve the stabilization package negotiated with the WSF, including the commitments to the EU Commission. Subsequent to the Supervisory Board's decision, the company intends to convene an Extraordinary General Meeting in the near future to obtain shareholder approval for the WSF stabilization measures.

ShowHide Related Items >><<
DLAKY Lufthansa
$0.00 /

+ (+0.00%)

DLAKY Lufthansa
$0.00 /

+ (+0.00%)

05/29/20 Citi
Citi opens 'positive catalyst watch' on Sell-rated Lufthansa
05/26/20 Citi
Lufthansa bailout 'marginally positive' for United Airlines,says Citi
05/06/20 HSBC
Lufthansa downgraded to Reduce from Hold at HSBC
04/24/20 Barclays
Lufthansa price target lowered to EUR 6.20 from EUR 12.70 at Barclays
DLAKY Lufthansa
$0.00 /

+ (+0.00%)

DLAKY Lufthansa
$0.00 /

+ (+0.00%)

Hot Stocks
SPDR Gold Shares holdings rise to 1,123.14MT from 1,119.63MT » 17:59
05/29/20
05/29
17:59
05/29/20
17:59
GLD

SPDR Gold Shares

$162.90 /

+1.17 (+0.72%)

This is the third…

This is the third consecutive increase and the highest level of holdings since April of 2013.

ShowHide Related Items >><<
GLD SPDR Gold Shares
$162.90 /

+1.17 (+0.72%)

GLD SPDR Gold Shares
$162.90 /

+1.17 (+0.72%)

GLD SPDR Gold Shares
$162.90 /

+1.17 (+0.72%)

GLD SPDR Gold Shares
$162.90 /

+1.17 (+0.72%)

Hot Stocks
Evolent Health: Passport Health not chosen for Kentucky MCO contract » 17:40
05/29/20
05/29
17:40
05/29/20
17:40
EVH

Evolent Health

$8.89 /

-0.17 (-1.88%)

Evolent Health announced…

Evolent Health announced that its partner, Passport Health Plan, received notification from the Kentucky Cabinet for Health and Family Services that Passport has not been awarded a Kentucky Managed Care Organization contract for the next contract period, which commences January 1, 2021. Evolent will support Passport in protesting this decision. Evolent will continue to provide services to Passport until the new Medicaid contracts take effect on January 1, 2021.

ShowHide Related Items >><<
EVH Evolent Health
$8.89 /

-0.17 (-1.88%)

EVH Evolent Health
$8.89 /

-0.17 (-1.88%)

03/26/20 Cowen
Cowen sees three healthcare IT names poised for rebound
02/26/20 Cantor Fitzgerald
Evolent Health price target lowered to $14 from $16 at Cantor Fitzgerald
02/26/20 Piper Sandler
Evolent Health price target raised to $17 from $10.15 at Piper Sandler
01/23/20 Cantor Fitzgerald
Evolent Health price target raised to $16 from $10 at Cantor Fitzgerald
EVH Evolent Health
$8.89 /

-0.17 (-1.88%)

EVH Evolent Health
$8.89 /

-0.17 (-1.88%)

EVH Evolent Health
$8.89 /

-0.17 (-1.88%)

EVH Evolent Health
$8.89 /

-0.17 (-1.88%)

Periodicals
Germany, EU reach pact on Lufthansa bailout, Bloomberg says » 17:36
05/29/20
05/29
17:36
05/29/20
17:36
DLAKY

Lufthansa

$0.00 /

+ (+0.00%)

Germany has struck an…

Germany has struck an agreement with the European Commission on Lufthansa's landing slots at hub airports, which could clear the path for the company's approval of Germany's $9.9B bailout offer, Bloomberg's Arne Delfs and William Wilkes report, citing a government official. Following days of talks, the EU and German government agreed that the carrier will cut the number of planes it kept at Frankfurt and Munich airports and let rival airlines take up flight slots, the authors note. Reference Link

ShowHide Related Items >><<
DLAKY Lufthansa
$0.00 /

+ (+0.00%)

DLAKY Lufthansa
$0.00 /

+ (+0.00%)

05/29/20 Citi
Citi opens 'positive catalyst watch' on Sell-rated Lufthansa
05/26/20 Citi
Lufthansa bailout 'marginally positive' for United Airlines,says Citi
05/06/20 HSBC
Lufthansa downgraded to Reduce from Hold at HSBC
04/24/20 Barclays
Lufthansa price target lowered to EUR 6.20 from EUR 12.70 at Barclays
DLAKY Lufthansa
$0.00 /

+ (+0.00%)

DLAKY Lufthansa
$0.00 /

+ (+0.00%)

Hot Stocks
PDL Community Bancorp authorizes buyback for up to 5% of outstanding stock » 17:29
05/29/20
05/29
17:29
05/29/20
17:29
PDLB

PDL Community Bancorp

$8.96 /

-0.02 (-0.22%)

PDL Community Bancorp…

PDL Community Bancorp announced that its board has adopted a share repurchase program intended to enhance shareholder value effective June 1, 2020. Under the repurchase program, the company may repurchase up to 864,987 shares of its common stock, or approximately 5% of the current outstanding shares.

ShowHide Related Items >><<
PDLB PDL Community Bancorp
$8.96 /

-0.02 (-0.22%)

Syndicate
Diffusion Pharmaceuticals files to sell 5.82M shares of common stock for holders  17:22
05/29/20
05/29
17:22
05/29/20
17:22
DFFN

Diffusion Pharmaceuticals

$1.30 /

+0.01 (+0.78%)

 
ShowHide Related Items >><<
DFFN Diffusion Pharmaceuticals
$1.30 /

+0.01 (+0.78%)

DFFN Diffusion Pharmaceuticals
$1.30 /

+0.01 (+0.78%)

12/18/19 H.C. Wainwright
Diffusion price target lowered to $3.50 from $10 at H.C. Wainwright
Hot Stocks
General Dynamics awarded $3.42B Army contract for Hydra-70 rocket systems » 17:21
05/29/20
05/29
17:21
05/29/20
17:21
GD

General Dynamics

$146.85 /

-1.675 (-1.13%)

General Dynamics was…

General Dynamics was awarded a $3.42B hybrid contract for production and engineering services for Hydra-70 rocket systems. Bids were solicited via the internet with one received. Work locations and funding will be determined with each order, with an estimated completion date of September 30, 2026. U.S. Army Contracting Command is the contracting activity.

ShowHide Related Items >><<
GD General Dynamics
$146.85 /

-1.675 (-1.13%)

GD General Dynamics
$146.85 /

-1.675 (-1.13%)

05/20/20 RBC Capital
RBC Capital starts General Dynamics at Outperform on sub 'dominance'
05/20/20 RBC Capital
General Dynamics initiated with an Outperform at RBC Capital
05/19/20 Seaport Global
Seaport Global starts 'underappreciated' General Dynamics at Buy
05/19/20 Seaport Global
General Dynamics initiated with a Buy at Seaport Global
GD General Dynamics
$146.85 /

-1.675 (-1.13%)

GD General Dynamics
$146.85 /

-1.675 (-1.13%)

GD General Dynamics
$146.85 /

-1.675 (-1.13%)

GD General Dynamics
$146.85 /

-1.675 (-1.13%)

Syndicate
CHF Solutions files to sell 1.8M shares of common stock for holders  17:08
05/29/20
05/29
17:08
05/29/20
17:08
CHFS

CHF Solutions

$0.38 /

-0.0029 (-0.77%)

 
ShowHide Related Items >><<
CHFS CHF Solutions
$0.38 /

-0.0029 (-0.77%)

CHFS CHF Solutions
$0.38 /

-0.0029 (-0.77%)

General news
Treasury Market Summary » 17:05
05/29/20
05/29
17:05
05/29/20
17:05

Treasury Market Summary:…

Treasury Market Summary: t was mostly a waiting game for the markets on Friday as May came to an end. The focus on two events today, the press conference from President Trump, and the comments from Fed Chair Powell. But neither really said anything new or surprising. Jitters over U.S.-China relations and fears the President could outline harsh sanctions saw risk appetite fade ahead of his comments with the Dow and S&amp;P 500 sliding just over 1%. But there was a big sigh of relief as he refrained from imposing any harsh economic or financial measures, while stating what had been indicated Wednesday by Secretary of State Pompeo that the U.S. would be ending its special treatment of Hong Kong. The President also didn't mention tariffs or ending the phase one trade deal. The NASDAQ closed with a solid 1.29% gain, while the S&amp;P 500 was up 0.48%. The Dow closed 0.07% lower. Treasuries rallied into the finish, led by the long end amid a record June 1 duration extension index, and still reflecting some haven demand after historically weak spending and export data. Chair Powell merely reiterated the FOMC was not looking to shift to a negative rate stance, while there was no mention of yield curve controls. View the summary.

Syndicate
Athersys files to sell 35M shares of common stock  17:04
05/29/20
05/29
17:04
05/29/20
17:04
ATHX

Athersys

$2.89 /

+0.11 (+3.96%)

 
ShowHide Related Items >><<
ATHX Athersys
$2.89 /

+0.11 (+3.96%)

ATHX Athersys
$2.89 /

+0.11 (+3.96%)

04/23/20 SMBC Nikko
Athersys initiated with an Outperform at SMBC Nikko
08/26/19 Dawson James
Athersys initiated with a Buy at Dawson James
ATHX Athersys
$2.89 /

+0.11 (+3.96%)

ATHX Athersys
$2.89 /

+0.11 (+3.96%)

Hot Stocks
GSE Systems will not timely file Annual Report by extended due date of May 29 » 17:02
05/29/20
05/29
17:02
05/29/20
17:02
GVP

GSE Systems

$1.05 /

+0.02 (+1.94%)

GSE Systems announced…

GSE Systems announced that, due to circumstances primarily stemming from the COVID-19 pandemic, the company will not timely file its Annual Report on Form 10-K for the year ended December 31, 2019 by the extended due date of May 29. The company continues to work diligently with its auditors to complete its annual filing with the U.S. SEC as soon as reasonably practical and is targeting submission of this filing by June 15.

ShowHide Related Items >><<
GVP GSE Systems
$1.05 /

+0.02 (+1.94%)

Recommendations
Syros Pharmaceuticals ASCO update bodes well for ph1 data, says Roth Capital » 17:00
05/29/20
05/29
17:00
05/29/20
17:00
SYRS

Syros Pharmaceuticals

$9.77 /

+0.25 (+2.63%)

Roth Capital analyst…

Roth Capital analyst Zegbeh Jallah keeps his Buy rating and $17 price target on Syros Pharmaceuticals after the company presented preclinical data of SY-5609 at ASCO this morning, showing tumor growth inhibition and sustained tumor regression in BRAF and KRAS mutant tumors. The data support ongoing Phase 1 study which, if positive, could be a major catalyst when released in Q4 of this year, the analyst tells investors in a research note.

ShowHide Related Items >><<
SYRS Syros Pharmaceuticals
$9.77 /

+0.25 (+2.63%)

SYRS Syros Pharmaceuticals
$9.77 /

+0.25 (+2.63%)

05/29/20 Piper Sandler
Syros price target raised to $14 after ASCO update at Piper Sandler
04/23/20 JonesTrading
Syros Pharmaceuticals initiated with a Buy at JonesTrading
03/06/20 H.C. Wainwright
Syros Pharmaceuticals price target lowered to $8 from $10 at H.C. Wainwright
01/17/20 Wedbush
Syros Pharmaceuticals risk/reward balanced ahead of data readouts, says Wedbush
SYRS Syros Pharmaceuticals
$9.77 /

+0.25 (+2.63%)

Hot Stocks
Molina Healthcare wins Kentucky Medicaid contract » 16:55
05/29/20
05/29
16:55
05/29/20
16:55
MOH

Molina Healthcare

$185.86 /

-0.54 (-0.29%)

Molina Healthcare…

Molina Healthcare announced that its Kentucky health plan subsidiary has been selected as an awardee pursuant to the statewide Medicaid managed care RFP issued on January 10 by the Kentucky Cabinet for Health and Family Services, Department for Medicaid Services. The new contract for Molina's Kentucky health plan is expected to begin on January 1, 2021. Molina's Kentucky health plan is one of five managed care organizations selected to offer health care coverage to approximately 1.4M Medicaid beneficiaries through the Commonwealth of Kentucky's TANF, CHIP, and ABD programs.

ShowHide Related Items >><<
MOH Molina Healthcare
$185.86 /

-0.54 (-0.29%)

MOH Molina Healthcare
$185.86 /

-0.54 (-0.29%)

05/04/20 SunTrust
Molina Healthcare price target raised to $210 from $185 at SunTrust
05/04/20 Deutsche Bank
Molina Healthcare price target lowered to $188 from $206 at Deutsche Bank
04/14/20 Stephens
Molina Healthcare upgraded to Overweight from Equal Weight at Stephens
04/08/20 BofA
Molina Healthcare double-upgraded to Buy from Underperform at BofA
MOH Molina Healthcare
$185.86 /

-0.54 (-0.29%)

MOH Molina Healthcare
$185.86 /

-0.54 (-0.29%)

MOH Molina Healthcare
$185.86 /

-0.54 (-0.29%)

Hot Stocks
Moderna says first patients dosed in Phase 2 study of mRNA COVID-19 vaccine » 16:55
05/29/20
05/29
16:55
05/29/20
16:55
MRNA

Moderna

$61.45 /

+5.92 (+10.66%)

Moderna announced that…

Moderna announced that the first participants in each age cohort have been dosed in the company's Phase 2 study of its mRNA vaccine candidate against the novel coronavirus. This Phase 2 study, being conducted by Moderna under its own Investigational New Drug application, will evaluate the safety, reactogenicity and immunogenicity of two vaccinations of mRNA-1273 given 28 days apart. The company intends to enroll 600 healthy participants across two cohorts of adults ages 18-55 years and older adults ages 55 years and above. Each participant will be assigned to receive placebo, a 50 undefined or a 100 undefined dose at both vaccinations. Participants will be followed through 12 months after the second vaccination. Given the 25 undefined and 100 undefined dose levels in the Phase 1 study showed neutralizing antibody titers at or above convalescent sera and were generally well tolerated, the company has decided not to pursue the 250 undefined dose level in the Phase 2 study.

ShowHide Related Items >><<
MRNA Moderna
$61.45 /

+5.92 (+10.66%)

MRNA Moderna
$61.45 /

+5.92 (+10.66%)

05/26/20 Maxim
ADMA Biologics' use of plasma is 'oldest trick in pandemic playbook', says Maxim
05/20/20 Morgan Stanley
Moderna price target raised to $90 from $37 at Morgan Stanley
05/19/20 Piper Sandler
Piper trims Moderna target to $100 on capital raise dilution
05/19/20 BMO Capital
Moderna price target raised to $112 from $83 at BMO Capital
MRNA Moderna
$61.45 /

+5.92 (+10.66%)

MRNA Moderna
$61.45 /

+5.92 (+10.66%)

MRNA Moderna
$61.45 /

+5.92 (+10.66%)

MRNA Moderna
$61.45 /

+5.92 (+10.66%)

Hot Stocks
Green Growth Brands announces extension of stay under insolvency proceedings » 16:53
05/29/20
05/29
16:53
05/29/20
16:53
GGBXF

Green Growth Brands

$0.00 /

+ (+0.00%)

Green Growth Brands…

Green Growth Brands provided an update on its insolvency proceedings under the companies' Creditors Arrangement Act, or CCAA. As announced on May 20, the company filed for insolvency protection under the CCAA and obtained an order from the Ontario Superior Court of Justice granting the applicants protection under the CCAA for an initial 10 day period until May 29. On May 29, the court extended the stay period until June 12 and adjourned to June 1 the hearing to consider a motion filed by the company to: increase the amount of the court-ordered charge over the applicants' assets, property and undertakings in connection with the applicants' debtor-in-possession financing agreement with All Js Greenspace; approve the implementation of a sale and investment solicitation process and approve a stalking-horse agreement among the company, All Js and Capital Transfer Agency in its capacity as the debentureholder trustee of the company's $45.5M aggregate principal amount of 15.00% secured convertible debentures that matured May 17 and $23.72M aggregate principal amount of 5.00% secured convertible debentures maturing in 2024 pursuant to which the Secured Credit Bidders would act as stalking-horse bidders under the SISP. The company intends to provide further updates on the CCAA proceedings and SISP process when there are significant developments.

ShowHide Related Items >><<
GGBXF Green Growth Brands
$0.00 /

+ (+0.00%)

GGBXF Green Growth Brands
$0.00 /

+ (+0.00%)

02/14/20 Cantor Fitzgerald
Cantor initiates 10 cannabis names, sees opportunity after sellofff
02/13/20 Cantor Fitzgerald
Green Growth Brands initiated with an Underweight at Cantor Fitzgerald
Periodicals
Germany, EU reach pact on Lufthansa bailout, Bloomberg says  16:48
05/29/20
05/29
16:48
05/29/20
16:48
DLAKY

Lufthansa

$0.00 /

+ (+0.00%)

 
ShowHide Related Items >><<
DLAKY Lufthansa
$0.00 /

+ (+0.00%)

DLAKY Lufthansa
$0.00 /

+ (+0.00%)

05/29/20 Citi
Citi opens 'positive catalyst watch' on Sell-rated Lufthansa
05/26/20 Citi
Lufthansa bailout 'marginally positive' for United Airlines,says Citi
05/06/20 HSBC
Lufthansa downgraded to Reduce from Hold at HSBC
04/24/20 Barclays
Lufthansa price target lowered to EUR 6.20 from EUR 12.70 at Barclays
DLAKY Lufthansa
$0.00 /

+ (+0.00%)

DLAKY Lufthansa
$0.00 /

+ (+0.00%)

Hot Stocks
Provident Financial Services, SB One Bancorp get FDIC approval for merger » 16:47
05/29/20
05/29
16:47
05/29/20
16:47
SBBX

SB One Bancorp

$16.84 /

-0.98 (-5.50%)

, PFS

Provident Financial

$13.07 /

-0.6 (-4.39%)

Provident Financial…

Provident Financial Services (PFS) and SB One Bancorp (SBBX) announced the receipt of the Federal Deposit Insurance Corporation and the New Jersey Department of Banking and Insurance approvals in connection with the proposed merger of SB One with and into Provident. The closing of the Merger remains subject to the approval of or waiver by the Board of Governors of the Federal Reserve System, the approval of SB One's shareholders at the annual meeting of shareholders to be held on June 24, 2020, and certain other customary closing conditions.

ShowHide Related Items >><<
SBBX SB One Bancorp
$16.84 /

-0.98 (-5.50%)

PFS Provident Financial
$13.07 /

-0.6 (-4.39%)

SBBX SB One Bancorp
$16.84 /

-0.98 (-5.50%)

03/13/20 DA Davidson
SB One Bancorp downgraded to Neutral from Buy at DA Davidson
03/13/20 Boenning & Scattergood
Provident upgraded to Outperform from Neutral at Boenning & Scattergood
03/13/20 Boenning & Scattergood
SB One Bancorp downgraded to Neutral from Outperform at Boenning & Scattergood
11/26/19 DA Davidson
SB One Bancorp initiated with a Buy at DA Davidson
PFS Provident Financial
$13.07 /

-0.6 (-4.39%)

10/11/19 RBC Capital
Provident Financial initiated with a Sector Perform rating at RBC Capital
SBBX SB One Bancorp
$16.84 /

-0.98 (-5.50%)

PFS Provident Financial
$13.07 /

-0.6 (-4.39%)

Syndicate
Red Robin files $75M mixed securities shelf  16:43
05/29/20
05/29
16:43
05/29/20
16:43
RRGB

Red Robin

$13.95 /

-0.66 (-4.52%)

 
ShowHide Related Items >><<
RRGB Red Robin
$13.95 /

-0.66 (-4.52%)

RRGB Red Robin
$13.95 /

-0.66 (-4.52%)

02/26/20 Wells Fargo
Red Robin price target lowered to $30 from $35 at Wells Fargo
01/15/20 Maxim
Red Robin seeing early signs of turnaround, says Maxim
11/06/19 Loop Capital
Red Robin price target lowered to $33 from $36 at Loop Capital
09/05/19 Stephens
Red Robin back to 'trust me' story after takeover rejection, says Stephens
RRGB Red Robin
$13.95 /

-0.66 (-4.52%)

RRGB Red Robin
$13.95 /

-0.66 (-4.52%)

RRGB Red Robin
$13.95 /

-0.66 (-4.52%)

Hot Stocks
Exponent authorizes additional $45M share buyback » 16:42
05/29/20
05/29
16:42
05/29/20
16:42
EXPO

Exponent

$74.23 /

-0.46 (-0.62%)

In a regulatory 8-K…

In a regulatory 8-K filing, Exponent announced it has "authorized an additional $45M for share repurchases adding to the existing $30M available under the current authorization for repurchase. In total, the company now has $75M available to repurchase shares."

ShowHide Related Items >><<
EXPO Exponent
$74.23 /

-0.46 (-0.62%)

EXPO Exponent
$74.23 /

-0.46 (-0.62%)

05/13/20 Sidoti
Exponent upgraded to Buy from Neutral at Sidoti
04/09/20 Sidoti
Exponent downgraded to Neutral from Buy at Sidoti
03/19/20 Sidoti
Exponent upgraded to Buy from Neutral at Sidoti
03/19/20 Sidoti
Exponent upgraded to Buy from Neutral at Sidoti
EXPO Exponent
$74.23 /

-0.46 (-0.62%)

EXPO Exponent
$74.23 /

-0.46 (-0.62%)

Syndicate
Paramount Gold Nevada files $25M mixed securities shelf  16:40
05/29/20
05/29
16:40
05/29/20
16:40
PZG

Paramount Gold Nevada

$1.12 /

+0.03 (+2.75%)

 
ShowHide Related Items >><<
PZG Paramount Gold Nevada
$1.12 /

+0.03 (+2.75%)

Conference/Events
Autolus Therapeutics to hold a pharmaceutical update conference call » 16:40
05/29/20
05/29
16:40
05/29/20
16:40
AUTL

Autolus Therapeutics

$12.52 /

+1.23 (+10.89%)

Management discusses the…

Management discusses the data on AUTO3 in DLBCL presented at the Virtual Annual Meeting of ASCO 2020 on a conference call to be held on June 1 at 8:30 am. Webcast Link

ShowHide Related Items >><<
AUTL Autolus Therapeutics
$12.52 /

+1.23 (+10.89%)

AUTL Autolus Therapeutics
$12.52 /

+1.23 (+10.89%)

04/22/20 Mizuho
Mizuho starts Autolus Therapeutics with Buy rating, $18 target
04/21/20 Mizuho
Autolus Therapeutics initiated with a Buy at Mizuho
02/18/20 H.C. Wainwright
Now the time to get long Autolus Therapeutics, says H.C. Wainwright
09/23/19 Needham
Autolus Therapeutics initiated with a Buy at Needham
AUTL Autolus Therapeutics
$12.52 /

+1.23 (+10.89%)

On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:36
05/29/20
05/29
16:36
05/29/20
16:36
TWTR

Twitter

$30.97 /

-0.63 (-1.99%)

, FB

Facebook

$223.10 /

-2.04 (-0.91%)

, CRM

Salesforce

$174.89 /

-6.46 (-3.56%)

, OXY

Occidental Petroleum

$12.97 /

-0.68 (-4.98%)

, TCEHY

Tencent

$0.00 /

+ (+0.00%)

, WMG

Warner Music

$0.00 /

+ (+0.00%)

, COST

Costco

$308.26 /

-1.84 (-0.59%)

, ADAP

Adaptimmune

$11.05 /

+6.19 (+127.37%)

, GLUU

Glu Mobile

$9.95 /

+1.27 (+14.63%)

, WSM

Williams-Sonoma

$83.25 /

+10.07 (+13.76%)

, ARVN

Arvinas

$33.26 /

-11.52 (-25.73%)

, CGC

Canopy Growth

$17.36 /

-4.37 (-20.11%)

, JWN

Nordstrom

$16.21 /

-1.89 (-10.44%)

, NERV

Minerva

$3.70 /

-9.78 (-72.55%)

Stocks were mostly weaker…

Open Full Text

ShowHide Related Items >><<
WSM Williams-Sonoma
$83.25 /

+10.07 (+13.76%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

OXY Occidental Petroleum
$12.97 /

-0.68 (-4.98%)

NERV Minerva
$3.70 /

-9.78 (-72.55%)

JWN Nordstrom
$16.21 /

-1.89 (-10.44%)

GLUU Glu Mobile
$9.95 /

+1.27 (+14.63%)

FB Facebook
$223.10 /

-2.04 (-0.91%)

CRM Salesforce
$174.89 /

-6.46 (-3.56%)

COST Costco
$308.26 /

-1.84 (-0.59%)

CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

ARVN Arvinas
$33.26 /

-11.52 (-25.73%)

ADAP Adaptimmune
$11.05 /

+6.19 (+127.37%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

05/29/20 Baird
Twitter, Facebook pullbacks would likely be buying opportunities, says Baird
05/29/20 JPMorgan
Trump order may put 'overhang' on big tech in coming months, says JPMorgan
05/27/20 Cowen
Cowen says Twitter 'will be fine,' but Republicans could support Facebook suit
05/06/20 China Renaissance
Twitter price target lowered to $23 from $25 at China Renaissance
FB Facebook
$223.10 /

-2.04 (-0.91%)

05/27/20 Citi
Facebook price target raised to $275 from $245 at Citi
CRM Salesforce
$174.89 /

-6.46 (-3.56%)

05/29/20 Morgan Stanley
Morgan Stanley remain buyers of Salesforce despite 'frustration' with margins
05/29/20 Mizuho
Salesforce price target raised to $210 from $205 at Mizuho
05/29/20 Wells Fargo
Salesforce price target raised to $215 from $200 at Wells Fargo
05/28/20 Needham
Workday price target raised to $200 from $175 at Needham
OXY Occidental Petroleum
$12.97 /

-0.68 (-4.98%)

05/18/20 Standpoint Research
Occidental Petroleum upgraded to Buy from Hold at Standpoint Research
05/07/20
Fly Intel: Top five analyst upgrades
05/07/20 SunTrust
Occidental Petroleum upgraded to Hold from Sell at SunTrust
05/06/20 SunTrust
Occidental Petroleum upgraded to Hold from Sell at SunTrust
TCEHY Tencent
$0.00 /

+ (+0.00%)

05/14/20 Benchmark
Tencent price target raised to HK$560 from HK$440 at Benchmark
05/14/20 Mizuho
Tencent price target raised to HK$410 from HK$355 at Mizuho
03/23/20 Oppenheimer
Tencent, Baidu, Alibaba attractive at current levels, says Oppenheimer
03/20/20 China Renaissance
Huya upgraded to Buy on valuation at China Renaissance
WMG Warner Music
$0.00 /

+ (+0.00%)

COST Costco
$308.26 /

-1.84 (-0.59%)

05/29/20 Baird
Costco improved comps seen likely for May, says Baird
05/29/20 RBC Capital
Costco price target raised to $348 from $332 at RBC Capital
05/06/20 Baird
Costco SSS decline due to pressure from temporal factors, says Baird
04/15/20 Citi
Costco assumed with a Neutral at Citi
ADAP Adaptimmune
$11.05 /

+6.19 (+127.37%)

05/29/20 JonesTrading
JonesTrading upgrades Adaptimmune to Buy after data alleviates 'key concern'
05/29/20 JonesTrading
Adaptimmune upgraded to Buy from Hold at JonesTrading
05/29/20 Mizuho
Adaptimmune data 'incrementally supportive,' but still early, says Mizuho
04/21/20 Mizuho
Adaptimmune initiated with a Neutral at Mizuho
GLUU Glu Mobile
$9.95 /

+1.27 (+14.63%)

05/29/20 Benchmark
Benchmark reiterates Buy rating on Glu Mobile after guidance hike
05/29/20 Piper Sandler
Glu Mobile outlook still conservative despite uptick, says Piper Sandler
05/11/20
Fly Intel: Top five analyst downgrades
05/11/20 Morgan Stanley
Morgan Stanley downgrades Glu Mobile after stock nearly doubled
WSM Williams-Sonoma
$83.25 /

+10.07 (+13.76%)

05/29/20 Wedbush
Williams-Sonoma price target raised to $90 from $80 at Wedbush
05/29/20 RBC Capital
Williams-Sonoma price target raised to $76 from $70 at RBC Capital
05/26/20 Telsey Advisory
Williams-Sonoma upgraded to Outperform from Market Perform at Telsey Advisory
05/18/20 Wedbush
Williams-Sonoma upgraded to Outperform at Wedbush
ARVN Arvinas
$33.26 /

-11.52 (-25.73%)

05/29/20 Roth Capital
Roth Capital recommends buying Arvinas on ASCO dip
05/29/20 Piper Sandler
Arvinas should be bought on weakness after ASCO update, says Piper Sandler
05/15/20 Roth Capital
Roth Capital maintains positive outlook on Arvinas after ASCO abstract review
05/13/20 Piper Sandler
Arvinas pullback represents a buying opportunity, says Piper Sandler
CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

05/22/20 BofA
Canopy Growth resumed with a Buy at BofA
05/14/20 Cantor Fitzgerald
Canopy Growth price target lowered to C$25 from C$27 at Cantor Fitzgerald
04/16/20
Fly Intel: Top five analyst upgrades
04/16/20 Jefferies
Canopy Growth upgraded to Hold following pullback at Jefferies
JWN Nordstrom
$16.21 /

-1.89 (-10.44%)

05/14/20 KeyBanc
Farfetch, Nordstrom, Revolve could be impacted by Amazon offering, says KeyBanc
05/07/20 Deutsche Bank
Nordstrom price target lowered to $18 from $35 at Deutsche Bank
04/30/20 Wedbush
Nordstrom price target lowered to $20 from $36 at Wedbush
03/27/20 Cleveland Research
Nordstrom downgraded at Cleveland Research, says QTD net sales have slowed
NERV Minerva
$3.70 /

-9.78 (-72.55%)

05/29/20 Jefferies
Jefferies downgrades Minerva to Hold on unclear path for roluperidone
05/29/20 Jefferies
Minerva downgraded to Hold from Buy at Jefferies
05/29/20 H.C. Wainwright
H.C. Wainwright sees path forward for Minerva's roluperidone despite setback
05/29/20 William Blair
Minerva downgraded to Market Perform from Outperform at William Blair
WSM Williams-Sonoma
$83.25 /

+10.07 (+13.76%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

OXY Occidental Petroleum
$12.97 /

-0.68 (-4.98%)

NERV Minerva
$3.70 /

-9.78 (-72.55%)

JWN Nordstrom
$16.21 /

-1.89 (-10.44%)

GLUU Glu Mobile
$9.95 /

+1.27 (+14.63%)

FB Facebook
$223.10 /

-2.04 (-0.91%)

CRM Salesforce
$174.89 /

-6.46 (-3.56%)

COST Costco
$308.26 /

-1.84 (-0.59%)

CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

ARVN Arvinas
$33.26 /

-11.52 (-25.73%)

ADAP Adaptimmune
$11.05 /

+6.19 (+127.37%)

  • 03
    Jun
TWTR Twitter
$30.97 /

-0.63 (-1.99%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

OXY Occidental Petroleum
$12.97 /

-0.68 (-4.98%)

JWN Nordstrom
$16.21 /

-1.89 (-10.44%)

FB Facebook
$223.10 /

-2.04 (-0.91%)

CRM Salesforce
$174.89 /

-6.46 (-3.56%)

COST Costco
$308.26 /

-1.84 (-0.59%)

CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

WSM Williams-Sonoma
$83.25 /

+10.07 (+13.76%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

OXY Occidental Petroleum
$12.97 /

-0.68 (-4.98%)

JWN Nordstrom
$16.21 /

-1.89 (-10.44%)

GLUU Glu Mobile
$9.95 /

+1.27 (+14.63%)

CRM Salesforce
$174.89 /

-6.46 (-3.56%)

COST Costco
$308.26 /

-1.84 (-0.59%)

CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

ARVN Arvinas
$33.26 /

-11.52 (-25.73%)

ADAP Adaptimmune
$11.05 /

+6.19 (+127.37%)

WSM Williams-Sonoma
$83.25 /

+10.07 (+13.76%)

TWTR Twitter
$30.97 /

-0.63 (-1.99%)

OXY Occidental Petroleum
$12.97 /

-0.68 (-4.98%)

JWN Nordstrom
$16.21 /

-1.89 (-10.44%)

GLUU Glu Mobile
$9.95 /

+1.27 (+14.63%)

FB Facebook
$223.10 /

-2.04 (-0.91%)

CRM Salesforce
$174.89 /

-6.46 (-3.56%)

COST Costco
$308.26 /

-1.84 (-0.59%)

CGC Canopy Growth
$17.36 /

-4.37 (-20.11%)

ADAP Adaptimmune
$11.05 /

+6.19 (+127.37%)

Hot Stocks
Plexus General Counsel sells 8.4K shares of common stock » 16:35
05/29/20
05/29
16:35
05/29/20
16:35
PLXS

Plexus

$64.24 /

-1.54 (-2.34%)

In a regulatory filing,…

In a regulatory filing, Plexus disclosed that its General Counsel Angelo Ninivaggi sold 8.4K shares of common stock on May 27th in a total transaction size of over $550K.

ShowHide Related Items >><<
PLXS Plexus
$64.24 /

-1.54 (-2.34%)

PLXS Plexus
$64.24 /

-1.54 (-2.34%)

04/20/20 Loop Capital
Plexus initiated with a Buy at Loop Capital
03/24/20 Needham
Plexus price target lowered to $67 from $80 at Needham
03/11/20 Sidoti
Plexus upgraded to Buy from Neutral at Sidoti
03/11/20 JPMorgan
JPMorgan downgrades TTM Technologies to Neutral, prefers others in space
PLXS Plexus
$64.24 /

-1.54 (-2.34%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.